Surgical Imaging Device (lights up cancer cells) could hit Europe this year

An Atlanta, Georgia company developing surgical imaging technology for image-guided cancer surgery is looking to add $6 million in anticipation of its European product launch.

Spectropath Inc.’s technology is a disposable, handheld, pen-like device used with an agent to make cancerous tissue turn a fluorescent color during tumor removal surgery, said President and CEO Ralph Gaskins Jr.

Complete removal of cancer is a critical predictor of patient survival, so more complete and accurate removal of tissue during surgery could reduce the need for chemotherapy and radiation treatment and improve outcomes, the company says.

Read more